国药现代(600420.SH)：盐酸戊乙奎醚注射液获得药品注册证书

Core Viewpoint - The approval of the drug registration certificate for the injection of Pentylquaternary Ammonium Hydrochloride by China National Pharmaceutical Group Modern Co., Ltd. is expected to enhance the company's product portfolio and market competitiveness, positively impacting future development [1] Group 1 - The injection of Pentylquaternary Ammonium Hydrochloride is a selective anticholinergic drug used for pre-anesthetic medication to suppress salivary and airway gland secretion, as well as for emergency treatment of organophosphate poisoning [1] - The product (1ml:1mg) has received the drug registration certificate from the National Medical Products Administration, which is considered equivalent to passing the consistency evaluation [1] - This approval will enrich the company's product offerings and strengthen its overall market competitiveness [1]